Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in Pediatr Infect Dis J

Retrieve available abstracts of 126 articles:
HTML format
Text format



Single Articles


    March 2018
  1. MAJEKODUNMI AO, Callard R, Klein N, Lewis J, et al
    Re: Recovery of CD4 T Cells in HIV/HCV Coinfected Children: Is it Really Impaired?
    Pediatr Infect Dis J. 2018;37:278-279.
    PubMed     Text format    


  2. FERNANDEZ MCPHEE C, Sainz T, Navarro ML
    Recovery of CD4 T Cells in HIV/HCV Coinfected Children: Is it Really Impaired?
    Pediatr Infect Dis J. 2018;37:278.
    PubMed     Text format    


    February 2018
  3. CRANMER LM, Draper HR, Mandalakas AM, Kim S, et al
    High Incidence of Tuberculosis Infection in HIV-Exposed Children Exiting an Isoniazid Preventive Therapy Trial.
    Pediatr Infect Dis J. 2018 Feb 16. doi: 10.1097/INF.0000000000001946.
    PubMed     Text format     Abstract available


  4. GOMEZ LA, Crowell CS, Njuguna I, Cranmer LM, et al
    Improved Neurodevelopment Following Antiretroviral Therapy in HIV-Infected Children.
    Pediatr Infect Dis J. 2018 Feb 12. doi: 10.1097/INF.0000000000001942.
    PubMed     Text format     Abstract available


  5. JESSON J, Dahourou DL, Folquet MA, Malateste K, et al
    Malnutrition, Growth Response and Metabolic Changes Within the First 24 Months After ART Initiation in HIV-Infected Children Treated Before the Age of Two Years in West Africa.
    Pediatr Infect Dis J. 2018 Feb 3. doi: 10.1097/INF.0000000000001932.
    PubMed     Text format     Abstract available


  6. BESTE S, Essajee S, Siberry G, Hannaford A, et al
    Optimal Antiretroviral Prophylaxis in Infants at High Risk of Acquiring HIV: A Systematic Review.
    Pediatr Infect Dis J. 2018;37:169-175.
    PubMed     Text format     Abstract available


    January 2018
  7. MAKADZANGE AT, Dougherty L, Birri R, Kupakuwana G, et al
    Temporal Improvements in Long-Term Outcome in Care Among HIV Infected Children Enrolled in Public ART Care: An Analysis of Outcomes From 2004-2012 in Zimbabwe.
    Pediatr Infect Dis J. 2018 Jan 18. doi: 10.1097/INF.0000000000001903.
    PubMed     Text format     Abstract available


  8. SETH A, Malhotra RK, Gupta R, Chandra J, et al
    Effect of Antiretroviral Therapy on Growth Parameters of Children With HIV Infection.
    Pediatr Infect Dis J. 2018;37:85-89.
    PubMed     Text format     Abstract available


    December 2017
  9. CHARAN J, Goyal JP, Reljic T, Emmanuel P, et al
    Isoniazid for the Prevention of Tuberculosis in HIV-Infected Children: A Systematic Review and Meta-Analysis.
    Pediatr Infect Dis J. 2017 Dec 26. doi: 10.1097/INF.0000000000001879.
    PubMed     Text format     Abstract available


  10. RICE ML, Russell JS, Frederick T, Purswani M, et al
    Risk for Speech and Language Impairments in Pre-school Aged HIV-Exposed Uninfected Children with in utero Combination Antiretroviral Exposure.
    Pediatr Infect Dis J. 2017 Dec 22. doi: 10.1097/INF.0000000000001875.
    PubMed     Text format     Abstract available


  11. BROPHY J, Bitnun A, Alimenti A, Lapointe N, et al
    Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in Girls Living with HIV.
    Pediatr Infect Dis J. 2017 Dec 22. doi: 10.1097/INF.0000000000001874.
    PubMed     Text format     Abstract available


  12. BELARD S, Heuvelings CC, Banderker E, Bateman L, et al
    Utility of Point-of-Care Ultrasound in Children with Pulmonary Tuberculosis.
    Pediatr Infect Dis J. 2017 Dec 22. doi: 10.1097/INF.0000000000001872.
    PubMed     Text format     Abstract available


  13. BAKER AN, Bayer AM, Viani RM, Kolevic L, et al
    Morbidity and Mortality of a Cohort of Peruvian HIV-Infected Children 2003-2012.
    Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001865.
    PubMed     Text format     Abstract available


  14. BUCEK A, Leu CS, Benson S, Warne P, et al
    Psychiatric Disorders, Antiretroviral Medication Adherence, and Viremia in a Cohort of Perinatally HIV-Infected Adolescents and Young Adults.
    Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001866.
    PubMed     Text format     Abstract available


  15. ARCHARY M, Mcllleron H, Bobat R, La Russa P, et al
    Population Pharmacokinetics of Lopinavir in Severely Malnourished HIV Infected Children and the Effect on Treatment Outcomes.
    Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001867.
    PubMed     Text format     Abstract available


  16. SEVINSKY H, Zaru L, Wang R, Xu X, et al
    Pharmacokinetics and Pharmacodynamics of Atazanavir in HIV-1-Infected Children Treated With Atazanavir Powder and Ritonavir: Combined Analysis of the PRINCE-1 and -2 Studies.
    Pediatr Infect Dis J. 2017 Dec 4. doi: 10.1097/INF.0000000000001855.
    PubMed     Text format     Abstract available


  17. COTTON MF, Liberty A, Torres-Escobar I, Gonzalez-Tome MI, et al
    Safety and Efficacy of Atazanavir Powder and Ritonavir in HIV-1-Infected Infants and Children Aged From 3 Months to <11 Years: the PRINCE-2 Study.
    Pediatr Infect Dis J. 2017 Dec 4. doi: 10.1097/INF.0000000000001856.
    PubMed     Text format     Abstract available


  18. DEHORITY W, Viani RM, Araneta MRG, Lopez G, et al
    Comparison of the QuantiFERON TB Gold In-tube Assay With Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection Among HIV-infected and Uninfected Children.
    Pediatr Infect Dis J. 2017;36:e317-e321.
    PubMed     Text format     Abstract available


  19. PAUL R, Prasitsuebsai W, Jahanashad N, Puthanakit T, et al
    Structural Neuroimaging and Neuropsychologic Signatures of Vertically Acquired HIV.
    Pediatr Infect Dis J. 2017 Dec 1. doi: 10.1097/INF.0000000000001852.
    PubMed     Text format     Abstract available


  20. SIBERRY GK
    Beyond Prevention of Vertical HIV Transmission - Improving Outcomes of HIV-Uninfected Infants Born to Mothers with HIV Infection.
    Pediatr Infect Dis J. 2017 Dec 1. doi: 10.1097/INF.0000000000001854.
    PubMed     Text format    


    November 2017
  21. PADMAPRIYADARSINI C, Shet A, Srinivasan R, Ramachandran G, et al
    High Prevalence of Lipid Abnormalities and Insulin Resistance Among Antiretroviral Naive HIV-Infected Children in India.
    Pediatr Infect Dis J. 2017 Nov 20. doi: 10.1097/INF.0000000000001829.
    PubMed     Text format     Abstract available


  22. ANGELIDOU KN, Palumbo P, Lindsey J, Violary A, et al
    Defining Study Outcomes That Better Reflect Individual Response to Treatment.
    Pediatr Infect Dis J. 2017 Nov 17. doi: 10.1097/INF.0000000000001766.
    PubMed     Text format     Abstract available


  23. MOYO F, Mazanderani AH, Barron P, Bhardwaj S, et al
    Introduction of Routine HIV Birth Testing in the South African National Consolidated Guidelines.
    Pediatr Infect Dis J. 2017 Nov 15. doi: 10.1097/INF.0000000000001840.
    PubMed     Text format     Abstract available


  24. JINDAL AK, Bhattad S, Suri D, Singhal M, et al
    Moyamoya Syndrome in a Child with HIV-1 Infection.
    Pediatr Infect Dis J. 2017 Nov 15. doi: 10.1097/INF.0000000000001841.
    PubMed     Text format     Abstract available


  25. SUCCI RC, Krauss MR, Harris DR, Machado DM, et al
    Immunity Following Childhood Vaccinations in Perinatally HIV-Exposed Children with and without HIV Infection in Latin America.
    Pediatr Infect Dis J. 2017 Nov 14. doi: 10.1097/INF.0000000000001831.
    PubMed     Text format     Abstract available


  26. MANDALAKAS AM, Highsmith HY, Harris NM, Pawlicka A, et al
    T-SPOT.TB(R) Performance in Routine Pediatric Practice in a Low TB Burden Setting.
    Pediatr Infect Dis J. 2017 Nov 14. doi: 10.1097/INF.0000000000001792.
    PubMed     Text format     Abstract available


  27. CORRIGAN B, Mukui I, Mulenga L, Mthethwa N, et al
    Characteristics of Treatment-Experienced HIV-infected African Children and Adolescents Initiating Darunavir and/or Etravirine-based Antiretroviral Treatment.
    Pediatr Infect Dis J. 2017 Nov 14. doi: 10.1097/INF.0000000000001843.
    PubMed     Text format     Abstract available


    October 2017
  28. PINTO JA, Capparelli EV, Warshaw M, Zimmer B, et al
    A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines.
    Pediatr Infect Dis J. 2017 Oct 28. doi: 10.1097/INF.0000000000001817.
    PubMed     Text format     Abstract available


  29. GIAQUINTO C, Mawela MP, Chokephaibulkit K, Negra MD, et al
    Pharmacokinetics, Safety, and Efficacy of Maraviroc in Treatment-Experienced Pediatric Patients Infected With CCR5-Tropic HIV-1.
    Pediatr Infect Dis J. 2017 Oct 7. doi: 10.1097/INF.0000000000001808.
    PubMed     Text format     Abstract available


  30. STANKIEVICH E, Malanca A, Foradori I, Ivalo S, et al
    Utility of Mobile Communication Devices as a Tool to Improve Adherence to Antiretroviral Treatment in HIV-Infected Children and Young Adults in Argentina.
    Pediatr Infect Dis J. 2017 Oct 7. doi: 10.1097/INF.0000000000001807.
    PubMed     Text format     Abstract available


  31. ROJAS SANCHEZ P, Dominguez S, Jimenez De Ory S, Prieto L, et al
    Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-Infected Pediatric Population in Madrid: 1993-2015 Analysis.
    Pediatr Infect Dis J. 2017 Oct 6. doi: 10.1097/INF.0000000000001760.
    PubMed     Text format     Abstract available


    September 2017
  32. ARYA BK, Bhattacharya SD, Sutcliffe CG, Ganaie F, et al
    Nasopharyngeal pneumococcal colonization and impact of a single dose of 13-valent pneumococcal conjugate vaccine in Indian children with HIV and their unvaccinated parents.
    Pediatr Infect Dis J. 2017 Sep 27. doi: 10.1097/INF.0000000000001800.
    PubMed     Text format     Abstract available


  33. SULIS G, Amadasi S, Odone A, Penazzato M, et al
    Antiretroviral Therapy in HIV Infected Children with Tuberculosis: A Systematic Review.
    Pediatr Infect Dis J. 2017 Sep 7. doi: 10.1097/INF.0000000000001784.
    PubMed     Text format     Abstract available


  34. HORMI M, Khourouj VG, Pommelet V, Jeljeli M, et al
    Performance of the QuantiFERON-TB Gold Assay Among HIV-infected Children with Active Tuberculosis in France.
    Pediatr Infect Dis J. 2017 Sep 5. doi: 10.1097/INF.0000000000001774.
    PubMed     Text format     Abstract available


    August 2017
  35. NDONGO FA, Texier G, Penda CI, Tejiokem MC, et al
    Virologic Response to Early Antiretroviral Therapy in HIV-Infected Infants: Evaluation After Two Years of Treatment in the Pediacam Study, Cameroon.
    Pediatr Infect Dis J. 2017 Aug 23. doi: 10.1097/INF.0000000000001745.
    PubMed     Text format     Abstract available


  36. BOSIRE R, Farquhar C, Nduati R, Broliden K, et al
    Higher Transplacental Pathogen-Specific Antibody Transfer Among Pregnant Women Randomized to Triple Antiretroviral Treatment Versus Short Course Zidovudine.
    Pediatr Infect Dis J. 2017 Aug 19. doi: 10.1097/INF.0000000000001749.
    PubMed     Text format     Abstract available


  37. JACOBSON DL, Lindsey JC, Coull BA, Mulligan K, et al
    The Association of Fat and Lean Tissue with Whole Body and Spine Bone Mineral Density is Modified by HIV Status and Sex in Children and Youth.
    Pediatr Infect Dis J. 2017 Aug 16. doi: 10.1097/INF.0000000000001715.
    PubMed     Text format     Abstract available


  38. KUMAR P, Suri D, Vignesh P, Attri SV, et al
    Metabolic Abnormalities and Clinical Lipodystrophy in Children with Human Immunodeficiency Virus Infection: A Report from A Tertiary-Care-Center in India.
    Pediatr Infect Dis J. 2017 Aug 3. doi: 10.1097/INF.0000000000001738.
    PubMed     Text format     Abstract available


  39. BONNET M, Nansumba M, Bastard M, Orikiriza P, et al
    Outcome of Children with Presumptive Tuberculosis in Mbarara, Rural Uganda.
    Pediatr Infect Dis J. 2017 Aug 2. doi: 10.1097/INF.0000000000001727.
    PubMed     Text format     Abstract available


  40. GARVIE PA, Brummel SS, Allison SM, Malee KM, et al
    Roles of Medication Responsibility, Executive and Adaptive Functioning in Adherence for Children and Adolescents With Perinatally Acquired HIV.
    Pediatr Infect Dis J. 2017;36:751-757.
    PubMed     Text format     Abstract available


  41. GOENKA A, Jeena PM, Mlisana K, Solomon T, et al
    Rapid Accurate Identification of Tuberculous Meningitis Among South African Children Using a Novel Clinical Decision Tool.
    Pediatr Infect Dis J. 2017 Aug 1. doi: 10.1097/INF.0000000000001726.
    PubMed     Text format     Abstract available


    July 2017
  42. DUNNING L, Kroon M, Fourie L, Ciaranello A, et al
    Impact of Birth HIV-PCR Testing on the Uptake at Follow-Up Early Infant Diagnosis Services in Cape Town, South Africa.
    Pediatr Infect Dis J. 2017 Jul 27. doi: 10.1097/INF.0000000000001677.
    PubMed     Text format     Abstract available


  43. HALL EW, Morris SB, Moore BK, Erasmus L, et al
    Treatment Outcomes of Children with HIV Infection and Drug-Resistant TB in Three Provinces in South Africa, 2005-2008.
    Pediatr Infect Dis J. 2017 Jul 19. doi: 10.1097/INF.0000000000001691.
    PubMed     Text format     Abstract available


  44. COKER M, El-Kamary S, Enwonwu C, Blattner W, et al
    Perinatal HIV Infection and Exposure and their Association with Dental Caries in Nigerian Children.
    Pediatr Infect Dis J. 2017 Jul 19. doi: 10.1097/INF.0000000000001702.
    PubMed     Text format     Abstract available


  45. BESTE S, Essajee S, Siberry G, Hannaford A, et al
    Optimal Anti-Retroviral Prophylaxis in Infants At High-Risk of Acquiring Human Immunodeficiency Virus: A Systematic Review.
    Pediatr Infect Dis J. 2017 Jul 18. doi: 10.1097/INF.0000000000001700.
    PubMed     Text format     Abstract available


  46. INNES S, van Toorn R, Otwombe K, Dobbels E, et al
    Late Onset HIV Encephalopathy in Children with Long-Standing Virologic Suppression Followed by Slow Spontaneous Recovery despite No Change in Antiretroviral Therapy -Four Case Reports.
    Pediatr Infect Dis J. 2017 Jul 15. doi: 10.1097/INF.0000000000001694.
    PubMed     Text format     Abstract available


  47. YANG H, Enimil A, Gillani FS, Antwi S, et al
    Evaluation of the Adequacy of the 2010 Revised World Health Organization Recommended Dosages of the First-line Antituberculosis Drugs for Children.
    Pediatr Infect Dis J. 2017 Jul 14. doi: 10.1097/INF.0000000000001687.
    PubMed     Text format     Abstract available


  48. BUNUPURADAH T, Phupitakphol T, Sophonphan J, Prasitsuebsai W, et al
    Prevalence of Persistent Renal Dysfunction in Perinatally HIV-infected Thai Adolescents.
    Pediatr Infect Dis J. 2017 Jul 13. doi: 10.1097/INF.0000000000001684.
    PubMed     Text format     Abstract available


    June 2017
  49. NJOM NLEND AE, Nga Motaze A, Tetang Ndiang S, Fokam J, et al
    Predictors of Virological Failure on First-Line Antiretroviral Therapy among Children in a Referral Pediatric Center in Cameroon.
    Pediatr Infect Dis J. 2017 Jun 28. doi: 10.1097/INF.0000000000001672.
    PubMed     Text format     Abstract available


  50. KIRKPATRICK AR, Unsal AB, Blankson JN, Moore RD, et al
    Weak HIV Antibody Responses in Perinatally-Infected Young Adults.
    Pediatr Infect Dis J. 2017 Jun 23. doi: 10.1097/INF.0000000000001649.
    PubMed     Text format     Abstract available


  51. SEERS T, Sarker D, Ross P, Heaton N, et al
    Hepatocellular Carcinoma in Perinatally Acquired HIV and HBV Co-Infection: A Case Report.
    Pediatr Infect Dis J. 2017 Jun 22. doi: 10.1097/INF.0000000000001662.
    PubMed     Text format     Abstract available


  52. HURST SA, Ewing AC, Ellington SR, Kourtis AP, et al
    Trends in Diagnoses Among Hospitalizations of HIV-Infected Children and Adolescents in the US: 2003-2012.
    Pediatr Infect Dis J. 2017 Jun 20. doi: 10.1097/INF.0000000000001645.
    PubMed     Text format     Abstract available


  53. KEKITIINWA A, Szubert AJ, Spyer M, Katuramu R, et al
    Virologic Response to First-line Efavirenz- or Nevirapine-based Antiretroviral Therapy in HIV-infected African Children.
    Pediatr Infect Dis J. 2017;36:588-594.
    PubMed     Text format     Abstract available


    May 2017
  54. PRASITSUEBSAI W, Sophonphan J, Chokephaibulkit K, Wongsawat J, et al
    Treatment Outcomes of Third-Line Antiretroviral Regimens in HIV-Infected Thai Adolescents.
    Pediatr Infect Dis J. 2017 May 16. doi: 10.1097/INF.0000000000001638.
    PubMed     Text format     Abstract available


  55. NAIK NM, Mbwanji RN, Mgawe M, Ongoa R, et al
    Pharmaceutical Dosing Errors at a Pediatric HIV Clinic in Mwanza, Tanzania.
    Pediatr Infect Dis J. 2017 May 11. doi: 10.1097/INF.0000000000001639.
    PubMed     Text format     Abstract available


  56. GONDRIE IPE, Bastiaans DET, Fraaij PLA, Driessen GJA, et al
    Sustained Viral Suppression in HIV-Infected Children on Once-Daily Lopinavir/ritonavir in Clinical Practice.
    Pediatr Infect Dis J. 2017 May 4. doi: 10.1097/INF.0000000000001627.
    PubMed     Text format     Abstract available


  57. JOAO EC, Gouvea MI, Teixeira ML, Mendes-Silva W, et al
    Zika Virus Infection Associated With Congenital Birth Defects in a HIV-infected Pregnant Woman.
    Pediatr Infect Dis J. 2017;36:500-501.
    PubMed     Text format     Abstract available


  58. LAZARUS E, Nicol S, Frigati L, Penazzato M, et al
    Second- and Third-line Antiretroviral Therapy for Children and Adolescents: A Scoping Review.
    Pediatr Infect Dis J. 2017;36:492-499.
    PubMed     Text format     Abstract available


  59. MAJEKODUNMI AO, Thorne C, Malyuta R, Volokha A, et al
    Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy.
    Pediatr Infect Dis J. 2017;36:e123-e129.
    PubMed     Text format     Abstract available


    April 2017
  60. LAPPHRA K, Oungkananukit P, Saihongthong S, Phongsamart W, et al
    Persistence of Hepatitis B Immunity Following 3-Dose Infant Primary Series in HIV-Infected Thai Adolescents and Immunologic Response to Revaccination.
    Pediatr Infect Dis J. 2017 Apr 17. doi: 10.1097/INF.0000000000001613.
    PubMed     Text format     Abstract available


  61. CONTRERAS GA, Murphy JR, Heresi GP
    Plasma Interferon Gamma-Inducible Protein 10 (IP10) Level Associates with Abnormal Memory B Cells Phenotypes in Perinatal HIV Infection.
    Pediatr Infect Dis J. 2017 Apr 17. doi: 10.1097/INF.0000000000001612.
    PubMed     Text format     Abstract available


  62. LEVIN C, Le Roux D, Harrison M, Tooke L, et al
    HIV Transmission to Premature Very Low Birth Weight Infants.
    Pediatr Infect Dis J. 2017 Apr 13. doi: 10.1097/INF.0000000000001611.
    PubMed     Text format     Abstract available


  63. KELLY MS, Surette MG, Smieja M, Pernica JM, et al
    The Nasopharyngeal Microbiota of Children with Respiratory Infections in Botswana.
    Pediatr Infect Dis J. 2017 Apr 10. doi: 10.1097/INF.0000000000001607.
    PubMed     Text format     Abstract available


  64. DZIUBAN EJ, DeVos J, Ngeno B, Ngugi E, et al
    High Prevalence of Abacavir-Associated L74V/I Mutations in Kenyan Children Failing Antiretroviral Therapy.
    Pediatr Infect Dis J. 2017 Apr 5. doi: 10.1097/INF.0000000000001597.
    PubMed     Text format     Abstract available


    March 2017
  65. BELARD S, Heller T, Orie V, Heuvelings CC, et al
    Sonographic Findings of Abdominal Tuberculosis in Children with Pulmonary Tuberculosis.
    Pediatr Infect Dis J. 2017 Mar 22. doi: 10.1097/INF.0000000000001590.
    PubMed     Text format     Abstract available


  66. RAMIREZ-AVILA L, Regan S, Cloete C, Crankshaw T, et al
    Adolescent Linkage to Care After a Large-scale Transfer From a Hospital-based HIV Clinic to the Public Sector in South Africa.
    Pediatr Infect Dis J. 2017;36:311-313.
    PubMed     Text format     Abstract available


    February 2017
  67. OMONI AO, Ntozini R, Evans C, Prendergast AJ, et al
    Child Growth According to Maternal and Child HIV Status in Zimbabwe.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001574.
    PubMed     Text format     Abstract available


  68. NEWMAN LP, Njoroge A, Magaret A, Chohan BH, et al
    Sustained Responses to Measles Revaccination at 24 Months in HIV-Infected Children on Antiretroviral Therapy in Kenya.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001572.
    PubMed     Text format     Abstract available


  69. CROWELL CS, Maiga AI, Sylla M, Taiwo B, et al
    High Rates of Baseline Drug Resistance and Virologic Failure Among ART Naive HIV-Infected Children in Mali.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001575.
    PubMed     Text format     Abstract available


  70. SLOGROVE AL, Esser MM, Cotton MF, Speert DP, et al
    A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants.
    Pediatr Infect Dis J. 2017;36:e38-e44.
    PubMed     Text format     Abstract available


    January 2017
  71. WALTERS E, van der Zalm MM, Palmer M, Bosch C, et al
    Xpert MTB/RIF on Stool is Useful for the Rapid Diagnosis of Tuberculosis in Young Children with Severe Pulmonary Disease.
    Pediatr Infect Dis J. 2017 Jan 31. doi: 10.1097/INF.0000000000001563.
    PubMed     Text format     Abstract available


  72. STALTER RM, Katayamoyo P, Packer C, Banda H, et al
    Transitioning to Second-Line Antiretroviral Therapy Among Adolescents in Copperbelt Province, Zambia: Predictors of Treatment Switching and Adherence to Second-Line Regimens.
    Pediatr Infect Dis J. 2017 Jan 16. doi: 10.1097/INF.0000000000001547.
    PubMed     Text format     Abstract available


  73. DIRAJLAL-FARGO S, Musiime V, Cook A, Mirembe G, et al
    Insulin Resistance and Markers of Inflammation in HIV-Infected Ugandan Children in the CHAPAS 3 Trial.
    Pediatr Infect Dis J. 2017 Jan 6. doi: 10.1097/INF.0000000000001544.
    PubMed     Text format     Abstract available


  74. RAINSBURY PG, Sharp J, Tappin A, Hussey M, et al
    Ritonavir and Topical Ocular Corticosteroid Induced Cushing's Syndrome in an Adolescent with HIV-1 Infection.
    Pediatr Infect Dis J. 2017 Jan 3. doi: 10.1097/INF.0000000000001534.
    PubMed     Text format     Abstract available


  75. SHEAHAN A, Feinstein L, Dube Q, Edmonds A, et al
    Early Antiretroviral Therapy Initiation and Mortality Among Infants Diagnosed with HIV in the First 12 Weeks of Life: Experiences from Kinshasa, DR Congo and Blantyre, Malawi.
    Pediatr Infect Dis J. 2017 Jan 3. doi: 10.1097/INF.0000000000001539.
    PubMed     Text format     Abstract available


  76. SANYAHUMBI AS, Hosseinipour M, Guffey D, Hoffman I, et al
    HIV Infected Children in Malawi have Decreased Performance on the 6 Minute Walk Test with Preserved Cardiac Mechanics Regardless of Antiretroviral Treatment Status.
    Pediatr Infect Dis J. 2017 Jan 3. doi: 10.1097/INF.0000000000001540.
    PubMed     Text format     Abstract available


    December 2016
  77. CURTIS CR, Baughman AL, DeBolt C, Goodykoontz S, et al
    Risk Factors Associated with Bordetella pertussis among Infants Aged </=4 Months in the pre-Tdap Era - United States, 2002-2005.
    Pediatr Infect Dis J. 2016 Dec 28. doi: 10.1097/INF.0000000000001528.
    PubMed     Text format     Abstract available


  78. KOLASA M, Tsai Y, Xu J, Fenlon N, et al
    Hepatitis B surface Antigen Testing Among Pregnant Women, United States 2014.
    Pediatr Infect Dis J. 2016 Dec 27. doi: 10.1097/INF.0000000000001516.
    PubMed     Text format     Abstract available


  79. ABRAMS EJ, Woldesenbet S, Silva JS, Coovadia A, et al
    Despite Access to Antiretrovirals for Prevention and Treatment High Rates of Mortality Persist Among HIV-infected Infants and Young Children.
    Pediatr Infect Dis J. 2016 Dec 23. doi: 10.1097/INF.0000000000001507.
    PubMed     Text format     Abstract available


  80. FRIGATI L, Wynberg E, Maritz J, Holgate S, et al
    Antiretroviral Treatment Initiated in the First Month of Life.
    Pediatr Infect Dis J. 2016 Dec 23. doi: 10.1097/INF.0000000000001504.
    PubMed     Text format     Abstract available


  81. KEKITIINWA A, Szubert AJ, Spyer M, Katuramu R, et al
    Virologic Response to First-Line Efavirenz- or Nevirapine-Based Anti-Retroviral Therapy in HIV-Infected African Children.
    Pediatr Infect Dis J. 2016 Dec 23. doi: 10.1097/INF.0000000000001505.
    PubMed     Text format     Abstract available


  82. JIMENEZ B, Sainz T, Diaz L, Mellado MJ, et al
    Low Bone Mineral Density in Vertically HIV-Infected Children and Adolescents: Risk Factors and the Role of T-Cell Activation and Senescence.
    Pediatr Infect Dis J. 2016 Dec 21. doi: 10.1097/INF.0000000000001506.
    PubMed     Text format     Abstract available


  83. AURPIBUL L, Lumbiganon P, Hansudewechakul R, Kanjanavanit S, et al
    Response to Tenofovir Among Lamivudine-Experienced Hepatitis B and HIV Coinfected Adolescents.
    Pediatr Infect Dis J. 2016 Dec 21. doi: 10.1097/INF.0000000000001491.
    PubMed     Text format     Abstract available


  84. LAZARUS E, Nicol S, Frigati L, Penazzato M, et al
    Second and Third Line Antiretroviral Therapy for Children and Adolescents: A Scoping Review.
    Pediatr Infect Dis J. 2016 Dec 15. doi: 10.1097/INF.0000000000001481.
    PubMed     Text format     Abstract available


  85. MAJEKODUNMI AO, Thorne C, Malyuta R, Volokha A, et al
    Hepatitis C Co-Infection and CD4+ T Cell Recovery in HIV-Infected Children Receiving Anti-Retroviral Therapy.
    Pediatr Infect Dis J. 2016 Dec 15. doi: 10.1097/INF.0000000000001478.
    PubMed     Text format     Abstract available


  86. JOAO EC, da Silveira Gouvea MI, de Lourdes Benamor Teixeira M, Mendes-Silva W, et al
    Zika Virus Infection Associated with Congenital Birth Defects in a HIV-Infected Pregnant Woman.
    Pediatr Infect Dis J. 2016 Dec 15. doi: 10.1097/INF.0000000000001482.
    PubMed     Text format     Abstract available


  87. CAMES C, Pascal L, Diack A, Mbodj H, et al
    Risk Factors for Growth Retardation in HIV-Infected Senegalese Children on Antiretroviral Treatment: The ANRS 12279 MAGGSEN Pediatric Cohort Study.
    Pediatr Infect Dis J. 2016 Dec 13. doi: 10.1097/INF.0000000000001454.
    PubMed     Text format     Abstract available


  88. ATTIA EF, Weiss NS, Maleche-Obimbo E, McGrath CJ, et al
    Risk Factors for Hypoxia and Tachypnea Among Adolescents with Vertically-Acquired HIV in Nairobi.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    November 2016
  89. LORENZO CR, Netto EM, Patricio FR, Brites C, et al
    Survival Estimates and Mortality Risk Factors in a Cohort of HIV Vertically Infected Individuals in Salvador, Brazil.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format    


  90. KENNY J, Doerholt K, Gibb DM, Judd A, et al
    Who Gets Severe Gynecomastia Among HIV-Infected Children In The UK And Ireland?
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  91. SUTCLIFFE CG, Searle K, Matakala HK, Biomed D, et al
    Measles and Rubella Seroprevalence Among HIV-Infected And Uninfected Zambian Youth.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  92. ESPIAU M, Yeste D, Noguera-Julian A, Soler-Palacin P, et al
    Adiponectin, Leptin and Inflammatory Markers in HIV-Associated Metabolic Syndrome in Children and Adolescents.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  93. VUPPULA S, Tyungu D, Kaul A, Chandwani S, et al
    A Thirty-Year Perspective of the Long-Term Survival, CD4 Percentage and Social Achievements of Perinatally HIV- Infected Children as a Function of Their Birth Era.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  94. VIEL-THERIAULT I, Thibeault R, Boucher FD, Drolet JP, et al
    Thalidomide in Refractory Tuberculomas and Pseudoabscesses.
    Pediatr Infect Dis J. 2016;35:1262-1264.
    PubMed     Text format     Abstract available


  95. CYAMATARE RWABUKWISI F, Hedt-Gauthier BL, Ribakare M, Mukamana J, et al
    Five-year Outcomes Among Children Receiving Antiretroviral Therapy in a Community-based Accompaniment Program in Rural Rwanda.
    Pediatr Infect Dis J. 2016;35:1222-1224.
    PubMed     Text format     Abstract available


  96. ARYA BK, Bhattacharya SD, Sutcliffe CG, Kumar Niyogi S, et al
    Impact of Haemophilus influenzae Type B Conjugate Vaccines on Nasopharyngeal Carriage in HIV-infected Children and Their Parents From West Bengal, India.
    Pediatr Infect Dis J. 2016;35:e339-e347.
    PubMed     Text format     Abstract available


    October 2016
  97. OSORIO LE, Boechat MI, Mirochnick M, Kumwenda N, et al
    Bone Age and Mineral Density Assessments Using Plain Roentgenograms in Tenofovir- Exposed Infants in Malawi and Brazil Enrolled in HIV Prevention Trials Network (HPTN) 057.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  98. SMITH ER, Sheahan AD, Heyderman RS, Miller WC, et al
    Performance of HIV Rapid Tests Among Breastfeeding, Malawian Infants.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  99. JACOBSON DL, Patel K, Williams PL, Geffner ME, et al
    Growth at Two Years of Age in HIV-Exposed Uninfected Children in the US by Trimester of Maternal Antiretroviral Initiation.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  100. MAMMEN VG, Dangor Z, Moore DP, Izu A, et al
    Hospitalization for Culture-Confirmed Pulmonary Tuberculosis in the Era of Childhood Pneumococcal Conjugate Vaccine Immunization.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  101. CLARKE DF, Yildirim I, Cooper ER
    Rapid Initiation of Antiretrovirals in Two Newly Diagnosed HIV Infected Infants.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  102. MATTINGLY AS, Unsal AB, Purdy JB, Gharib AM, et al
    T-Cell Activation and E-Selectin Are Associated with Coronary Plaque in HIV-Infected Young Adults.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  103. MELVIN AJ, Montepiedra G, Aaron L, Meyer WA 3rd, et al
    Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-Infected Children, Adolescents and Young Adults with Hyperlipidemia.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  104. TEASDALE CA, Yang J, Thome B, Yersin I, et al
    Outcomes Among Children Enrolled in HIV Care in Mozambique 2009-2013.
    Pediatr Infect Dis J. 2016;35:1117-25.
    PubMed     Text format     Abstract available


    September 2016
  105. LITTLE KM, Taylor AW, Borkowf CB, Mendoza MC, et al
    Perinatal Antiretroviral Exposure and Prevented Mother-to-Child HIV Infections in the Era of Antiretroviral Prophylaxis in the United States, 1994-2010.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  106. ROSS ECKARD A, Rosebush JC, Lee ST, O'Riordan MA, et al
    Increased Immune Activation and Exhaustion in HIV-Infected Youth.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    August 2016
  107. MOHOLISA RR, Schomaker M, Kuhn L, Castel S, et al
    Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-Experienced HIV-Infected Children.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  108. CRESSEY TR, Hazra R, Wiznia A, Foca M, et al
    Pharmacokinetics of Unboosted Atazanavir in Treatment-Experienced HIV-infected Children, Adolescents and Young Adults.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  109. ACHAN J, Kakuru A, Ikilezi G, Mwangwa F, et al
    Growth Recovery Among HIV-Infected Children Randomized to Lopinavir/Ritonavir or NNRTI-Based Antiretroviral Therapy.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    July 2016
  110. SAINZ T, Serrano-Villar S, Mellado MJ
    Prevalence of Elevated Blood Pressure in HIV-infected Children, Adolescents and Young Adults.
    Pediatr Infect Dis J. 2016;35:824-5.
    PubMed     Text format    


    June 2016
  111. GONZALEZ-DIAZ M, Urrea-Quezada A, Villegas-Gomez I, Durazo M, et al
    Cryptosporidium canis in Two Mexican Toddlers.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  112. VIEL-THERIAULT I, Thibeault R, Boucher FD, Drolet JP, et al
    Thalidomide in Refractory Tuberculomas and Pseudo-Abscesses.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  113. CYAMATARE FR, Hedt-Gauthier BL, Ribakare M, Mukamana J, et al
    Five-Year Outcomes Among Children Receiving Antiretroviral Therapy in a Community-Based Accompaniment Program in Rural Rwanda.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  114. DZIUBAN EJ, Rivadeneira ED
    Universal Antiretroviral Treatment Eligibility for Children and Adolescents Living with HIV: A New Era.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  115. LOMBAARD J, Bunupuradah T, Flynn PM, Ramapuram J, et al
    Rilpivirine as a Treatment for HIV-infected Antiretroviral-Naive Adolescents: Week 48 Safety, Efficacy, Virology and Pharmacokinetics.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  116. ARYA BK, Bhattacharya SD, Sutcliffe C, Niyogi SK, et al
    Impact of Haemophilus influenzae Type b Conjugate Vaccines (HibCV) on Nasopharyngeal Carriage in HIV Infected Children and Their Parents from West Bengal, India.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  117. VERANI JR, Groome MJ, Zar HJ, Zell ER, et al
    Risk Factors for Presumed Bacterial Pneumonia Among HIV-Uninfected Children Hospitalized in Soweto, South Africa.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    May 2016
  118. VIEIRA MT, Marlow MA, Aguiar-Alves F, Pinheiro MG, et al
    Living Conditions as a Driving Factor in Persistent Methicillin-Resistant Staphylococcus Aureus Colonization Among HIV-Infected Youth.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  119. SONEGO M, Sagrado MJ, Escobar G, Lazzerini M, et al
    Dyslipidemia, Diet, and Physical Exercise in Children on Treatment with Anti-Retroviral Medication in El Salvador: A Cross-Sectional Study.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  120. DAHINTEN AP, Dow DE, Cunningham CK, Msuya LJ, et al
    Providing Safe and Effective Preventative Antiretroviral Prophylaxis to HIV-Exposed Newborns Via a Novel Drug Delivery System in Tanzania.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  121. BASTARD M, Poulet E, Nicolay N, Szumilin E, et al
    Pediatric access and continuity of HIV care before the start of antiretroviral therapy in sub-Saharan Africa.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  122. NYAZIKA TK, Masanganise F, Hagen F, Bwakura-Dangarembizi MF, et al
    Cryptococcal Meningitis Presenting as a Complication in HIV-Infected Children: A Case Series from Sub-Saharan Africa.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  123. FOCA M, Yogev R, Wiznia A, Hazra R, et al
    Rilpivirine Pharmacokinetics Without and With Darunavir/ritonavir once daily in Adolescents and Young Adults.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  124. SCHERPBIER HJ, Terpstra V, Pajkrt D, Puthakanit T, et al
    Noncirrhotic Portal Hypertension in Perinatally HIV-Infected Adolescents Treated with Didanosine-Containing Antiretroviral Regimens in Childhood.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  125. SALOU M, Butel C, Konou AA, Ekouevi DK, et al
    High Rates of Drug Resistance Among Newly Diagnosed HIV-Infected Children in the National Prevention of Mother-To-Child Transmission Program in Togo.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  126. ADACHI K, Klausner JD, Xu J, Ank B, et al
    Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected Pregnant Women and Adverse Infant Outcomes.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: